Begüm Kurt

Prof. Dr. Begüm Kurt


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2025 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
SGSerife Ozlem Cagri Genc
Serife Ozlem Cagri Genc
Esra AKAYDIN GÜLTÜRKEsra AKAYDIN GÜLTÜRK
Esra AKAYDIN GÜLTÜRK
BKBegüm Kurt
Begüm Kurt
Purpose: Ovarian cancer (OC) is a leading cause of gynecologic cancer mortality, where accurate staging is vital for prognosis and treatment. This study aims to evaluate the prognostic potential of the Platelet-to-Lymphocyte Ratio (PLR), Prognostic Nutritional Index (PNI), and Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) scores in OC staging. Methods: The study was conducted at the Sivas Cumhuriyet University Faculty of Medicine, Department of Obstetrics and Gynecology, between January 1, 2009, and December 31, 2021. A total of 96 OC patients were retrospectively analyzed. Preoperative PLR, PNI, and HALP scores were calculated from routine laboratory parameters. Associations between these scores and clinicopathological factors, including OC stage, were evaluated. The discriminatory power of each index was assessed through ROC curve and AUC (area under the curve) analysis. Results: The AUC for PLR was 0.689 (p < 0.05), indicating significant prognostic value, while the HALP score showed an AUC of 0.671 (p < 0.05). Both markers were significantly associated with OC stages, with higher PLR and lower HALP scores correlating with advanced stages. In contrast, PNI demonstrated a lower AUC of 0.398 (p > 0.05), indicating limited prognostic utility. Conclusion: PLR and HALP scores are useful prognostic markers for OC staging, offering cost-effective and accessible tools in clinical practice. PNI, however, was less predictive. These findings suggest that PLR and HALP could complement existing staging methods, aiding in clinical decision-making. Future large-scale studies are warranted to validate these results.

20 May 2021
Verified
Book
Closed access
PDF file
BKBegüm Kurt
Begüm Kurt
BKBüşra Kanyıldız
Büşra Kanyıldız
EŞErdem Şahin
Erdem Şahin
YMYusuf Madendağ
Yusuf Madendağ
MKMehmet Mete Kırlangıç
Mehmet Mete Kırlangıç
HTHakan Gökalp Taş
Hakan Gökalp Taş
Based in Ankara in Turkey, the independent academic publisher, Akademisyen Publishing House, has been publishing books for almost 30 years. As the directors of Akademisyen Publishing House, we are proud to publish around 1500 books across disciplines so far, especially in Health Sciences. We also publish books in Social Sciences, Educational Sciences, Physical Sciences, and also books on cultural and artistic topics.Akademisyen Publishing House has recently commenced the process of publishing books in the international arena with the “Scientific Research Book” series in Turkish and English. The publication process of the books, which is expected to take place in March and September every year, will continue with thematic subtitles across disciplines

12 November 2024 in Cirugía y Cirujanos (English Edition)
Verified
Journal Article
Open access
PDF file
BKBegüm Kurt
Begüm Kurt
CYCaglar Yildiz
Caglar Yildiz
TKTulay Koc
Tulay Koc
NKNese Kurt-Ozkaya
Nese Kurt-Ozkaya
SCSerkan Celikgun
Serkan Celikgun
Objective: This study was carried out to investigate the effect of autologous platelet-rich plasma (PRP) on intra-abdominal adhesion at the cesarean section ...

16 November 2023 in Cirugía y Cirujanos
Verified
Journal Article
Open access
PDF file
BKBegüm Kurt
Begüm Kurt
KOKerim E. Oksuz
Kerim E. Oksuz
ZSZeynep D. Sahin-Inan
Zeynep D. Sahin-Inan
CHCeylan Hepokur
Ceylan Hepokur
Objective: In this study, we aimed to compare the anti-adhesive effects of contractubex and dicalcium phosphate dihydrate (DCPD) particles in rats treated with the uterine horn adhesion model. Materials and methods: Newly adult, 60 Wistar albino rats were used as experimental animals. The modified rat uterine horn adhesion model was used to induce intra-abdominal adhesion. Tumor necrosis factor (TNF)-α, interleukin (IL)-1, vascular endothelial growth factor (VEGF) and transforming growth factor (TGF)-β1 were studied for biochemical and immunohistochemical examination. Results: TNF-α decreased in each group, while it decreased more in G2 and G3 than in G1. IL-1β decreased in each group, while it decreased the most in G3. TGF-β1 and VEGF localization was less in the G2 compared to G1, the least TGF-β1 and VEGF immunolocalization was detected in the G3 and G4. For both antibodies, the least localization among all groups belonged to G3. From day 7 to day 21, the highest TGF-β1 immunolocalization was observed in G1, lesser localization in G2 and lowest in G3. Conclusion: DCPD nanoparticles show promise as a clinical antiadhesive agent and should be further evaluated in experimental animal models and human trials.

24 June 2023 in Cumhuriyet Medical Journal
Verified
Journal Article
Open access
PDF file
BKBegüm Kurt
Begüm Kurt
IKİrem Küçükyildiz
İrem Küçükyildiz
AYAli Yanik
Ali Yanik
Objective: We aimed to evaluate the prognostic role of preoperative serum cancer antigen 125 (CA-125) in endometrioid endometrial cancer for determining the cut-off values for clinicopathological factors. Study design: 161 patients were included in the study. The inclusion criteria were histopathological confirmation of endometrioid endometrial cancer and patients with CA-125 levels measured at most ten days before surgery. The association between CA-125 value and clinicopathological variables were analyzed. Receiver operating characteristic curve statistical tests with clinicopathological factors were used to determine the cut-off values and the prognostic role of CA-125. Results: The median value of CA-125 level was 15.4 (3, 2-577) IU/L. These CA-125 cut-off values ranged from 14.30 to 18.67 IU/L (sensitivity 53%– 100%, specificity 30%–59%). The statistical analysis showed a significant relation between CA-125 value and stage and pelvic-paraaortic lymph nodes metastasis. The average life expectancy of patients with CA-125 ≥15.4 was 102.8±5.9 months, whereas that of patients with CA-125 <15.4 was 120.1±3.4 months. Conclusion: Serum CA-125 levels with endometrioid endometrial cancer are related to the stage of the disease. Lower cut-off values compared to the traditional 35 IU/ml value used in ovarian cancer can be a prognostic factor in patients with endometrioid endometrial cancer.

8 December 2023 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
BKBegüm Kurt
Begüm Kurt
CHCeylan Hepokur
Ceylan Hepokur
ZIZeynep Deniz Şahin İnAn
Zeynep Deniz Şahin İnAn
IKİrEm Küçükyıldız
İrEm Küçükyıldız
The programed cell death gene-1 ligand (PDL-1) is expressed by villous syncytiotrophoblasts, cytotrophoblasts, and fetal cells in close contact with maternal tissue and blood. Programmed cell death gene-1 (PD-1) and the PDL-1 pathway cooperate with human leucocyte antigen-G (HLA-G), expressing intermediate trophoblastic cells and syncytiotrophoblasts to inhibit the function of activated T-cells. With this mechanism, the immunosuppressive microenvironment protects the placenta. This study investigated changes in PD-1 and PD-L1 gene expression in patients with a history of recurrent pregnancy loss (RPL). Sixty patients participated in the study and were divided into three groups. Group 1 (G1): healthy pregnancy, G2: RPL but not low-molecular-weight heparin (LMWH), and G3: RPL and LMWH. PD-1 gene expression in placental tissue samples was measured by reverse-transcriptase polymerase chain reaction and PD-L1 Elisa assay, and the study was supported by histopathology. The PD-L1 value decreased significantly in G2. A significant difference was observed between the groups in PD-1 gene expression levels in G1 and G2. It was observed that vascularization increased and the villi structures intensified in G3. In G2, there was villus dysplasia in the placenta, enlargement in the intervillous region, and fibrin deposition. It was observed that the villi structures in G3 returned to a morphology similar to that of G1. T-cells are activated in patients using LMWH, and a new therapeutic strategy can be developed to prevent pregnancy loss by targeting the PD-1 pathway.